Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-22 Purchase | 2024-01-24 6:44 pm | Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. See Remarks 10% Owner | 476,190 | $21 | $9,999,990 | 1,845,813 (Indirect) | View |
| 2023-09-29 Purchase | 2023-10-03 4:00 pm | Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner | 24,670 | $13.63 | $336,252 | 1,928,503 (Indirect) | View |
| 2023-09-26 Purchase | 2023-09-28 5:09 pm | Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner | 30,000 | $13.15 | $394,500 | 1,903,833 (Indirect) | View |
| 2023-09-19 Purchase | 2023-09-21 4:23 pm | Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner | 30,000 | $13.2 | $396,000 | 1,873,833 (Indirect) | View |
| 2023-09-12 Purchase | 2023-09-13 9:17 pm | Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner | 24,254 | $11.2 | $271,680 | 1,850,333 (Indirect) | View |
| 2023-07-13 Purchase | 2023-07-17 8:00 pm | Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest II L.P. Kiselak Tomas Harwin Peter Evan Director | 2,941,176 | $17 | $49,999,992 | 988,045 (Indirect Direct) | View |
| 2023-06-09 Purchase | 2023-06-13 4:07 pm | Cogent Biosciences Inc. | COGT | Fairmount Funds Management LLC See Remarks 10% Owner | 800,000 | $12 | $9,600,000 | 3,626,389 (Indirect) | View |
| 2022-08-17 Purchase | 2022-08-19 4:32 pm | Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. See Remarks 10% Owner | 425,531 | $23.5 | $9,999,979 | 1,369,623 (Indirect) | View |
| 2022-06-16 Purchase | 2022-06-21 10:02 am | Cogent Biosciences Inc. | COGT | Fairmount Funds Management LLC See Remarks 10% Owner | 1,200,000 | $8.25 | $9,900,000 | 2,826,389 (Indirect) | View |
| 2021-09-21 Purchase | 2021-09-23 09:30 am | Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Director 10% Owner | 909,000 | $11 | $9,999,000 | 1,077,283 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-25 Exercise | 2024-04-25 4:55 pm | N/A N/A | Spyre Therapeutics Inc. | SYRE | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 3,730,672 | $0 | 5,176,222 (Indirect) | View |
| 2024-03-28 Other | 2024-04-01 6:32 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Director 10% Owner | 49,857 | $0 | 1,990,722 (Indirect) | View |
| 2024-04-01 Other | 2024-04-01 6:21 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Director | 58,857 | $0 | 2,880,551 (Indirect) | View |
| 2024-03-28 Other | 2024-04-01 6:19 pm | N/A N/A | Cogent Biosciences Inc. | COGT | Fairmount Funds Management LLC Director | 310,679 | $0 | 5,366,757 (Indirect) | View |
| 2024-03-28 Other | 2024-04-01 5:44 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 498,765 | $0 | 9,006,126 (Indirect) | View |
| 2024-02-16 Option Award | 2024-02-16 6:43 pm | N/A N/A | Cogent Biosciences Inc. | COGT | Fairmount Funds Management LLC 10% Owner | 1,500 | $7500 | 4,727,141 (Indirect) | View |
| 2024-02-16 Option Award | 2024-02-16 6:43 pm | N/A N/A | Cogent Biosciences Inc. | COGT | Fairmount Funds Management LLC 10% Owner | 1,166,666 | $7.5 | 4,727,141 (Indirect) | View |
| 2024-01-29 Other | 2024-01-31 4:31 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest II L.P. Kiselak Tomas Harwin Peter Evan Director | 943,695 | $0 | 1,046,027 (Indirect) | View |
| 2024-01-22 Option Award | 2024-01-24 7:02 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner | 834,334 | $12 | 3,595,170 (Indirect) | View |
| 2024-01-22 Option Award | 2024-01-24 7:02 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner | 832,333 | $12 | 3,595,170 (Indirect) | View |
| 2023-12-29 Other | 2023-12-29 5:00 pm | N/A N/A | Spyre Therapeutics Inc. | SYRE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 3,841,518 | $0 | 5,485,719 (Indirect) | View |
| 2023-12-07 Option Award | 2023-12-11 5:41 pm | N/A N/A | Spyre Therapeutics Inc. | SYRE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 16,667 | $600 | 16,667 (Indirect) | View |
| 2023-11-24 Conversion | 2023-11-28 4:05 pm | N/A N/A | Spyre Therapeutics Inc. | AGLE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 3,521,367 | $0 | 4,250,938 (Indirect) | View |
| 2023-10-30 Option Award | 2023-11-01 9:05 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. See Remarks 10% Owner | 48,463 | $825.37 | 48,463 (Indirect) | View |
| 2023-09-11 Option Award | 2023-09-13 9:17 pm | N/A 2033-09-10 | Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner | 6,500 | $0 | 1,850,333 (Indirect) | View |
Ownership | 2023-09-13 8:55 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner | 0 | $0 | 1,819,579 (Indirect) | View |
| 2023-07-13 Option Award | 2023-07-17 8:00 pm | N/A 2033-07-13 | Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest II L.P. Kiselak Tomas Harwin Peter Evan Director | 95,516 | $0 | 988,045 (Direct) | View |
Ownership | 2023-07-13 6:39 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Director | 0 | $0 | 6,743,321 (Indirect) | View |
Ownership | 2023-06-30 5:32 pm | N/A N/A | Aeglea BioTherapeutics Inc. | AGLE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 0 | $0 | 536,284,540 (Indirect) | View |
Ownership | 2020-10-30 11:43 am | N/A N/A | MIRAGEN THERAPEUTICS INC. | MGEN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. See Remarks | 0 | $0 | 131,717,393 (Indirect) | View |
| 2020-10-27 Other | 2020-10-29 11:30 am | N/A N/A | MIRAGEN THERAPEUTICS INC. | MGEN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. See Remarks | 625,247 | $0 | 1,063,749 (Indirect) | View |
| 2020-07-06 Other | 2020-07-08 7:29 pm | N/A N/A | Unum Therapeutics Inc. | UMRX | Fairmount Funds Management LLC 10% Owner | 6,280,590 | $0 | 11,369,087 (Indirect) | View |